CA Stock MarketDetailed Quotes

NGEN NervGen Pharma Corp

Watchlist
  • 2.690
  • -0.050-1.82%
15min DelayMarket Closed Jun 28 16:00 ET
188.11MMarket Cap-7911P/E (TTM)

NervGen Pharma Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
5.36%4.97M
-22.79%17.78M
-28.15%4.87M
-30.62%3.42M
-24.45%4.77M
-5.75%4.72M
79.73%23.03M
63.60%6.78M
34.27%4.92M
128.12%6.31M
Selling and administrative expenses
18.12%1.97M
51.96%9.63M
29.91%2.18M
48.98%2.55M
108.99%3.23M
19.20%1.67M
6.75%6.34M
4.10%1.68M
3.84%1.71M
-9.65%1.54M
-General and administrative expense
18.12%1.97M
51.96%9.63M
29.91%2.18M
48.98%2.55M
108.99%3.23M
19.20%1.67M
6.75%6.34M
4.10%1.68M
3.84%1.71M
-9.65%1.54M
Research and development costs
-1.65%2.97M
-51.57%8.05M
-47.48%2.67M
-73.71%837.57K
-68.00%1.52M
-16.11%3.02M
141.77%16.61M
100.60%5.08M
58.00%3.19M
352.75%4.75M
Depreciation amortization depletion
0.17%24.36K
34.36%98.57K
1.47%24.67K
2.89%25.02K
3.26%24.56K
2,467.69%24.32K
3,471.81%73.37K
3,057.92%24.32K
5,581.31%24.32K
125.03%23.79K
-Depreciation and amortization
0.17%24.36K
34.36%98.57K
1.47%24.67K
2.89%25.02K
3.26%24.56K
2,467.69%24.32K
3,471.81%73.37K
3,057.92%24.32K
5,581.31%24.32K
125.03%23.79K
Operating profit
-5.36%-4.97M
22.79%-17.78M
28.15%-4.87M
30.62%-3.42M
24.45%-4.77M
5.75%-4.72M
-79.73%-23.03M
-63.60%-6.78M
-34.27%-4.92M
-128.12%-6.31M
Net non-operating interest income (expenses)
-32.00%102.95K
275.63%550.07K
42.47%122.55K
130.34%136.55K
316.28%139.59K
773.19%151.39K
-1,164.70%-313.2K
569.88%86.01K
-6,954.81%-450.09K
528.80%33.53K
Non-operating interest income
-32.00%102.95K
173.13%550.07K
42.47%122.55K
111.67%136.55K
316.28%139.59K
773.19%151.39K
584.62%201.4K
569.88%86.01K
882.52%64.51K
528.80%33.53K
Non-operating interest expense
----
--0
--0
--0
----
----
--514.6K
--0
--514.6K
----
Other net income (expenses)
1,853.67%2.52M
-297.08%-5.16M
-608.91%-3.86M
-154.49%-1.02M
-238.73%-132.12K
-840.57%-143.77K
4,636.56%2.62M
5,889.78%757.77K
2,971.58%1.88M
-234.03%-39.01K
Gain on sale of security
1,853.67%2.52M
-297.08%-5.16M
-608.91%-3.86M
-154.49%-1.02M
-238.73%-132.12K
-840.57%-143.77K
4,636.56%2.62M
5,889.78%757.77K
2,971.58%1.88M
-234.03%-39.01K
Income before tax
50.19%-2.35M
-8.01%-22.38M
-44.92%-8.61M
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
2.87%-3.5M
-131.20%-6.32M
Income tax
Earnings from equity interest net of tax
Net income
50.19%-2.35M
-8.01%-22.38M
-44.92%-8.61M
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
2.87%-3.5M
-131.20%-6.32M
Net income continuous operations
50.19%-2.35M
-8.01%-22.38M
-44.92%-8.61M
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
2.87%-3.5M
-131.20%-6.32M
Noncontrolling interests
Net income attributable to the company
50.19%-2.35M
-8.01%-22.38M
-44.92%-8.61M
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
2.87%-3.5M
-131.20%-6.32M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
50.19%-2.35M
-8.01%-22.38M
-44.92%-8.61M
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
2.87%-3.5M
-131.20%-6.32M
Diluted earnings per share
50.00%-0.04
2.56%-0.38
-50.00%-0.15
-16.67%-0.07
38.46%-0.08
27.27%-0.08
-21.88%-0.39
-11.11%-0.1
33.33%-0.06
-85.71%-0.13
Basic earnings per share
50.00%-0.04
2.56%-0.38
-50.00%-0.15
-16.67%-0.07
38.46%-0.08
27.27%-0.08
-21.88%-0.39
-11.11%-0.1
33.33%-0.06
-85.71%-0.13
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 5.36%4.97M-22.79%17.78M-28.15%4.87M-30.62%3.42M-24.45%4.77M-5.75%4.72M79.73%23.03M63.60%6.78M34.27%4.92M128.12%6.31M
Selling and administrative expenses 18.12%1.97M51.96%9.63M29.91%2.18M48.98%2.55M108.99%3.23M19.20%1.67M6.75%6.34M4.10%1.68M3.84%1.71M-9.65%1.54M
-General and administrative expense 18.12%1.97M51.96%9.63M29.91%2.18M48.98%2.55M108.99%3.23M19.20%1.67M6.75%6.34M4.10%1.68M3.84%1.71M-9.65%1.54M
Research and development costs -1.65%2.97M-51.57%8.05M-47.48%2.67M-73.71%837.57K-68.00%1.52M-16.11%3.02M141.77%16.61M100.60%5.08M58.00%3.19M352.75%4.75M
Depreciation amortization depletion 0.17%24.36K34.36%98.57K1.47%24.67K2.89%25.02K3.26%24.56K2,467.69%24.32K3,471.81%73.37K3,057.92%24.32K5,581.31%24.32K125.03%23.79K
-Depreciation and amortization 0.17%24.36K34.36%98.57K1.47%24.67K2.89%25.02K3.26%24.56K2,467.69%24.32K3,471.81%73.37K3,057.92%24.32K5,581.31%24.32K125.03%23.79K
Operating profit -5.36%-4.97M22.79%-17.78M28.15%-4.87M30.62%-3.42M24.45%-4.77M5.75%-4.72M-79.73%-23.03M-63.60%-6.78M-34.27%-4.92M-128.12%-6.31M
Net non-operating interest income (expenses) -32.00%102.95K275.63%550.07K42.47%122.55K130.34%136.55K316.28%139.59K773.19%151.39K-1,164.70%-313.2K569.88%86.01K-6,954.81%-450.09K528.80%33.53K
Non-operating interest income -32.00%102.95K173.13%550.07K42.47%122.55K111.67%136.55K316.28%139.59K773.19%151.39K584.62%201.4K569.88%86.01K882.52%64.51K528.80%33.53K
Non-operating interest expense ------0--0--0----------514.6K--0--514.6K----
Other net income (expenses) 1,853.67%2.52M-297.08%-5.16M-608.91%-3.86M-154.49%-1.02M-238.73%-132.12K-840.57%-143.77K4,636.56%2.62M5,889.78%757.77K2,971.58%1.88M-234.03%-39.01K
Gain on sale of security 1,853.67%2.52M-297.08%-5.16M-608.91%-3.86M-154.49%-1.02M-238.73%-132.12K-840.57%-143.77K4,636.56%2.62M5,889.78%757.77K2,971.58%1.88M-234.03%-39.01K
Income before tax 50.19%-2.35M-8.01%-22.38M-44.92%-8.61M-23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M2.87%-3.5M-131.20%-6.32M
Income tax
Earnings from equity interest net of tax
Net income 50.19%-2.35M-8.01%-22.38M-44.92%-8.61M-23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M2.87%-3.5M-131.20%-6.32M
Net income continuous operations 50.19%-2.35M-8.01%-22.38M-44.92%-8.61M-23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M2.87%-3.5M-131.20%-6.32M
Noncontrolling interests
Net income attributable to the company 50.19%-2.35M-8.01%-22.38M-44.92%-8.61M-23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M2.87%-3.5M-131.20%-6.32M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 50.19%-2.35M-8.01%-22.38M-44.92%-8.61M-23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M2.87%-3.5M-131.20%-6.32M
Diluted earnings per share 50.00%-0.042.56%-0.38-50.00%-0.15-16.67%-0.0738.46%-0.0827.27%-0.08-21.88%-0.39-11.11%-0.133.33%-0.06-85.71%-0.13
Basic earnings per share 50.00%-0.042.56%-0.38-50.00%-0.15-16.67%-0.0738.46%-0.0827.27%-0.08-21.88%-0.39-11.11%-0.133.33%-0.06-85.71%-0.13
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg